[
  {
    "ts": "2026-01-09T16:12:18+00:00",
    "headline": "A Look At Elevance Health (ELV) Valuation After Recent Analyst Upgrades And Long Term Growth Optimism",
    "summary": "Multiple analyst upgrades, led by Wolfe Research and Wells Fargo, have pushed Elevance Health (ELV) into focus as investors weigh the company’s Medicare Advantage and Medicaid exposure against expectations for earnings to bottom in 2026. See our latest analysis for Elevance Health. The recent Wolfe Research and Wells Fargo upgrades came on top of a strong run, with Elevance Health’s 30 day share price return of 13.63% and 90 day share price return of 6.09%. At the same time, the 1 year total...",
    "url": "https://finance.yahoo.com/news/look-elevance-health-elv-valuation-161218196.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1f27b9e8-35c5-3718-83ab-e95a57577973",
      "content": {
        "id": "1f27b9e8-35c5-3718-83ab-e95a57577973",
        "contentType": "STORY",
        "title": "A Look At Elevance Health (ELV) Valuation After Recent Analyst Upgrades And Long Term Growth Optimism",
        "description": "",
        "summary": "Multiple analyst upgrades, led by Wolfe Research and Wells Fargo, have pushed Elevance Health (ELV) into focus as investors weigh the company’s Medicare Advantage and Medicaid exposure against expectations for earnings to bottom in 2026. See our latest analysis for Elevance Health. The recent Wolfe Research and Wells Fargo upgrades came on top of a strong run, with Elevance Health’s 30 day share price return of 13.63% and 90 day share price return of 6.09%. At the same time, the 1 year total...",
        "pubDate": "2026-01-09T16:12:18Z",
        "displayTime": "2026-01-09T16:12:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/En2KzBqo8SXnCw89zK0WLw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BoUVqO_whCETSPZRsj9Bbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-elevance-health-elv-valuation-161218196.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-elevance-health-elv-valuation-161218196.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-09T17:13:53+00:00",
    "headline": "Elevance Health (ELV) Is Up 6.9% After Wolfe Upgrade And Medicaid Focus - Has The Bull Case Changed?",
    "summary": "In early January 2026, Elevance Health drew renewed attention as Wolfe Research upgraded the managed-care sector and elevated its view on the company, while several other analysts and institutional investors also expressed increased confidence in Elevance’s outlook amid earlier pressure from higher Medicaid and Affordable Care Act costs. Despite recent earnings guidance cuts linked to rising government program costs, Elevance’s strong position in Medicare Advantage and Medicaid, coupled with...",
    "url": "https://finance.yahoo.com/news/elevance-health-elv-6-9-171353854.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ef056239-fc90-34d1-9315-9885a4ca9264",
      "content": {
        "id": "ef056239-fc90-34d1-9315-9885a4ca9264",
        "contentType": "STORY",
        "title": "Elevance Health (ELV) Is Up 6.9% After Wolfe Upgrade And Medicaid Focus - Has The Bull Case Changed?",
        "description": "",
        "summary": "In early January 2026, Elevance Health drew renewed attention as Wolfe Research upgraded the managed-care sector and elevated its view on the company, while several other analysts and institutional investors also expressed increased confidence in Elevance’s outlook amid earlier pressure from higher Medicaid and Affordable Care Act costs. Despite recent earnings guidance cuts linked to rising government program costs, Elevance’s strong position in Medicare Advantage and Medicaid, coupled with...",
        "pubDate": "2026-01-09T17:13:53Z",
        "displayTime": "2026-01-09T17:13:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/En2KzBqo8SXnCw89zK0WLw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BoUVqO_whCETSPZRsj9Bbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/elevance-health-elv-6-9-171353854.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/elevance-health-elv-6-9-171353854.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]